| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SEMNEPHROL.2010.01.011 |
| P8608 | Fatcat ID | release_7ydl7o7jmrb6hhfji4uxhs3bga |
| P932 | PMC publication ID | 2852315 |
| P698 | PubMed publication ID | 20347649 |
| P5875 | ResearchGate publication ID | 42610372 |
| P50 | author | Kimberly A Kaphingst | Q89169399 |
| P2093 | author name string | Colleen M McBride | |
| P2860 | cites work | Family history of breast cancer: what do women understand and recall about their genetic risk? | Q33681260 |
| Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial | Q34049921 | ||
| Goals of genetic counseling | Q34570462 | ||
| What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review | Q34682125 | ||
| Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors | Q34692294 | ||
| Hereditary renal cancers | Q35038205 | ||
| Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review | Q35044477 | ||
| American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility | Q35105968 | ||
| Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis | Q35603145 | ||
| Hereditary kidney cancer | Q35609575 | ||
| Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis | Q35634237 | ||
| Linking human genetics with molecular medicine: will hereditary renal cancer play a major role? | Q35683851 | ||
| Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors | Q35986971 | ||
| Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer | Q36149410 | ||
| Psychological impact of genetic testing for cancer susceptibility: an update of the literature | Q36153016 | ||
| Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement | Q36250211 | ||
| Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force | Q36250215 | ||
| The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress | Q36618237 | ||
| Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes | Q36694430 | ||
| Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy | Q81267790 | ||
| Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer | Q81771906 | ||
| Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma | Q81834388 | ||
| Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing | Q82966058 | ||
| "Talking About Chance": The Presentation of Risk Information During Genetic Counseling for Breast and Ovarian Cancer | Q85527780 | ||
| Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. | Q36696594 | ||
| Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics | Q36718934 | ||
| Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders | Q36879101 | ||
| Psychosocial and behavioral impact of genetic counseling and testing. | Q36961264 | ||
| Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history | Q37005478 | ||
| A systematic review of perceived risks, psychological and behavioral impacts of genetic testing | Q37057762 | ||
| Interventions to improve risk communication in clinical genetics: systematic review | Q37061382 | ||
| Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers | Q37090813 | ||
| Anchoring-and-adjustment bias in communication of disease risk | Q37157787 | ||
| Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities | Q37183447 | ||
| Familial and hereditary renal cancer syndromes | Q37320995 | ||
| Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome | Q37324996 | ||
| A systematic review of the impact of genetic counseling on risk perception accuracy. | Q37416415 | ||
| Genetic testing: considerations for pediatric nephrologists | Q37555046 | ||
| Assessment of genetic testing and related counseling services: current research and future directions | Q40533991 | ||
| BRCA1/2 genetic testing in the community setting | Q40621809 | ||
| Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. | Q40694571 | ||
| Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. | Q40907038 | ||
| The use of audiotapes in consultations with women from high risk breast cancer families: a randomised trial | Q43074557 | ||
| Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer | Q43075548 | ||
| Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families | Q46051887 | ||
| A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling | Q46361470 | ||
| The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation | Q46542512 | ||
| Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer | Q47289147 | ||
| Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. | Q50708880 | ||
| Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. | Q50787592 | ||
| ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. | Q50789980 | ||
| The diversity of PKD1 alleles: implications for disease pathogenesis and genetic counseling. | Q51741625 | ||
| Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. | Q51794096 | ||
| Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. | Q52123195 | ||
| Interventions to improve patient education regarding multifactorial genetic conditions: a systematic review. | Q53111020 | ||
| Psychological distress and quality of life associated with genetic testing for breast cancer risk. | Q53170233 | ||
| Genetic counseling forBRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process | Q57572372 | ||
| Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures | Q62978214 | ||
| Breast cancer risk counseling improves women’s functioning | Q63434914 | ||
| Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing | Q74008289 | ||
| Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? | Q74082982 | ||
| Pre-counseling education materials for BRCA testing: does tailoring make a difference? | Q74741436 | ||
| Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing | Q79214311 | ||
| Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients | Q79880210 | ||
| Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome | Q80723791 | ||
| Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations | Q80794920 | ||
| Benefit finding in response to BRCA1/2 testing | Q80890773 | ||
| Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors | Q81180461 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 203-214 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Seminars in Nephrology | Q15761561 |
| P1476 | title | Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice | |
| P478 | volume | 30 |
| Q64134042 | Cancer communication research in the era of genomics and precision medicine: a scoping review |
| Q34017520 | Communicating genetic and genomic information: health literacy and numeracy considerations |
| Q36312837 | Effects of informed consent for individual genome sequencing on relevant knowledge |
| Q36867826 | Effects of racial and ethnic group and health literacy on responses to genomic risk information in a medically underserved population. |
| Q38633533 | Healthcare professionals' and patients' perspectives on consent to clinical genetic testing: moving towards a more relational approach. |
| Q39695669 | Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer |
| Q34131978 | Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry |
| Q39864656 | Relationships Between Health Literacy and Genomics-Related Knowledge, Self-Efficacy, Perceived Importance, and Communication in a Medically Underserved Population |
Search more.